Serum zinc value in patients with hepatitis virus-related chronic liver disease: Association with the histological degree of liver fibrosis and with the severity of varices in compensated cirrhosis

Journal of Clinical Biochemistry and Nutrition

Volumn 55, Issue 2, 2014, Pages 147-152

  Iwata, Kazunari ^a,b   Enomoto, Hirayuki ^a   Nishiguchi, Shuhei ^a   Aizawa, Nobuhiro ^a   Sakai, Yoshiyuki ^a   Iwata, Yoshinori ^a   Tanaka, Hironori ^a   Ikeda, Naoto ^a   Takashima, Tomoyuki ^a   Saito, Masaki ^a   Imanishi, Hiroyasu ^a   Iijima, Hiroko ^a   Tsuda, Yasuhiro ^b   Higuchi, Kazuhide ^b  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Biomarker; Esophageal varices; Liver cirrhosis; Metabolism; Zinc

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; BRANCHED CHAIN AMINO ACID; HEMOGLOBIN; HEPATITIS B SURFACE ANTIGEN; ZINC;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BRANCHED CHAIN AMINO ACID TO TYROSINE RATIO; CHILD PUGH SCORE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ESOPHAGUS VARICES; ESOPHAGUS VARICES BLEEDING; FEMALE; HEMOGLOBIN BLOOD LEVEL; HEPATITIS; HEPATITIS B; HEPATITIS C; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; LIVER FIBROSIS; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; METAL METABOLISM; PROTHROMBIN TIME; THROMBOCYTE COUNT; ZINC BLOOD LEVEL; ZINC METABOLISM;

EID: 84908503508     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.14-33     Document Type: Article

References (35)

1. Chalasani N, Kahi C, Francois F, et al. Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol 2003; 98: 653-659.
2. D'Amico G, De Franchis R; Cooperative Study Group. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 2003; 38: 599-612.
3. Zhang C, Thabut D, Kamath PS, Shah VH. Oesophageal varices in cirrhotic patients: from variceal screening to primary prophylaxis of the first oesophageal variceal bleeding. Liver Int 2010; 31: 108-119.
4. Garcia-Tsao G, Lim JK; Members of Veterans Affairs Hepatitis C Resource Center Program. Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program. Am J Gastroenterol 2009; 104: 1802-1829.
5. de Franchis R; Baveno V Faculty. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010; 53: 762-768.
6. Sebastiani G, Tempesta D, Fattovich G, et al. Prediction of oesophageal varices in hepatic cirrhosis by simple serum non-invasive markers: results of a multicenter, large-scale study. J Hepatol 2010; 53: 630-638.
7. de Franchis R. Non-invasive (and minimally invasive) diagnosis of oesophageal varices. J Hepatol 2008; 49: 520-527.
8. Thabut D, Moreau R, Lebrec D. Noninvasive assessment of portal hypertension in patients with cirrhosis. Hepatology 2011; 53: 683-694.
9. McClain CJ, Kasarskis EJ Jr, Allen JJ. Functional consequences of zinc deficiency. Prog Food Nutr Sci 1985; 9: 185-226.
10. Krebs NF. Overview of zinc absorption and excretion in the human gastrointestinal tract. J Nutr 2000; 130 (5S Suppl): 1374S-1377S.
11. Matsuoka S, Matsumura H, Nakamura H, et al. Zinc supplementation improves the outcome of chronic hepatitis C and liver cirrhosis. J Clin Biochem Nutr 2009; 45: 292-303.
12. Himoto T, Hosomi N, Nakai S, et al. Efficacy of zinc administration in patients with hepatitis C virus-related chronic liver disease. Scand J Gastroenterol 2007; 42: 1078-1087.
13. Umeta M, West CE, Haidar J, Deurenberg P, Hautvast JG. Zinc supplementation and stunted infants in Ethiopia: a randomised controlled trial. Lancet 2000; 355: 2021-2026.
14. Bode JC, Hanisch P, Henning H, Koenig W, Richter FW, Bode C. Hepatic zinc content in patients with various stages of alcoholic liver disease and in patients with chronic active and chronic persistent hepatitis. Hepatology 1988; 8: 1605-1609.
15. Ishikawa T. Can zinc enhance response interferon therapy for patients with HCV-related liver disease? World J Gastroenterol 2012; 18: 3196-3200.
16. Takahashi M, Saito H, Higashimoto M, Hibi T. Possible inhibitory effect of oral zinc supplementation on hepatic fibrosis through down regulation of TIMP-1: A pilot study. Hepatol Res 2007; 37: 405-409.
17. The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994; 20: 15-20.
18. Paquet KJ. Prophylactic endoscopic sclerosing treatment of esophageal wall in varices-a prospective controlled trial. Endoscopy 1982; 14: 4-5.
19. Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38: 518-526.
20. Vallet-Pichard A, Mallet V, Nalpas B, et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. Hepatology 2007; 46: 32-36.
21. Enomoto H, Sakai Y, Aizawa N, et al. Association of amino acid imbalance with the severity of liver fibrosis and esophageal varices. Ann Hepatol 2013; 12: 471-478.
22. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W; Practice Guidelines Committee of the American Association for the Study of Liver Diseases; Practice Parameters Committee of the American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007; 46: 922-938.
23. Jalan R, Hayes PC. UK guidelines on the management of variceal haemorrhage in cirrhotic patients. British Society of Gastroenterology. Gut 2000; 46 (Suppl III): 1-15.
24. Schepis F, Cammà C, Niceforo D, et al. Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection? Hepatology 2001; 33: 333-338.
25. D'Amico G, Luca A. Natural history. Clinical-haemodynamic correlations. Prediction of the risk of bleeding. Baillieres Clin Gastroenterol 1997; 11: 243-256.
26. Eslam M, Ampuero J, Jover M, et al. Predicting portal hypertension and variceal bleeding using non-invasive measurements of metabolic variables. Ann Hepatol 2013; 12: 588-598.
27. Aizawa N, Enomoto H, Imanishi H, et al. Elevation of the glycated albumin to glycated hemoglobin ratio during the progression of hepatitis C virusrelated liver fibrosis. World J Hepatol 2012; 4: 11-17.
28. Bando Y, Kanehara H, Aoki K, et al. The glycated albumin to glycated haemoglobin ratio increases along with fibrosis stage in non-alcoholic steatohepatitis. Ann Clin Biochem 2012; 49 (Pt 4): 387-390.
29. Sakai Y, Enomoto H, Aizawa N, et al. Relationship between elevation of glycated albumin to glycated hemoglobin ratio in patients with a high bleeding risk of esophageal varices. Hepatogastroenterology 2012; 59: 2280-2284.
30. Riggio O, Merli M, Capocaccia L, et al. Zinc supplementation reduce blood ammonia and increases liver ornithine transcarbamylase activity in experimental cirrhosis. Hepatology 1992; 16: 785-789.
31. Ebara M, Fukuda H, Hatano R, et al. Metal contents in the liver of patients with chronic liver disease caused by hepatitis C virus. Reference to hepatocellular carcinoma. Oncology 2003; 65: 323-330.
32. Katayama K, Sakakibara M, Imanaka K, et al. Effect of zinc supplementation in patients with type C liver cirrhosis. Open J Gastroenterol 2011; 1: 28-34.
33. Sebastiani G, Castera L, Halfon P, et al. The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases. Aliment Pharmacol Ther 2011; 34: 1202-1216.
34. Jin W, Lin Z, Xin Y, Jiang X, Dong Q, Xuan S. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysis. BMC Gastroenterol 2012; 12: 14.
35. Qamar AA, Grace ND, Groszmann RJ, et al. Platelet count is not a predictor of the presence or development of gastroesophageal varices in cirrhosis. Hepatology 2008; 47: 153-159.